Syra Health Corp. SYRA
0.88
0.02
2.33%
as of 25 Sep
- Market cap
- $1.1M
- P/E
- 90.0×
Follow SYRA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(45.71%) | (36.02%) | (7.60%) | 5.18% | |
| (32.94%) | (27.79%) | (4.78%) | 3.58% | ||
ROIC |
(340.92%) | (116.91%) | 0.00% | 9.15% | |
Return on Tangible Assets |
(58.46%) | (43.29%) | (7.79%) | 5.11% | |
Average Days of Receivables |
45.09 | 46.39 | 41.51 | 66.32 | |
Free Cash Flow per Share |
(0.03) | (0.04) | 0.06 | 0.01 | |
Free Cash Flow |
(0.37) | (0.45) | 0.76 | 0.11 | |
Capital Expenditures |
— | (0.01) | — | — | |
Piotroski F-Score |
3.00 | 4.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(8.92%) | (12.06%) | 14.31% | 2.31% | |
Accounts Receivable Turnover |
8.28 | 9.04 | 8.42 | 6.87 | |
Accounts Payable Turnover |
19.86 | 27.14 | 13.80 | 13.04 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
22.00 | 19.07 | 28.03 | 14.55 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.83% | 0.94% | 0.49% | 0.68% | |
Selling, General and Administrative Expense of Revenue |
36.23% | 35.51% | 30.84% | 29.30% | |
Share Based Compensation of Revenue |
1.42% | 1.36% | 1.16% | 1.10% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.29 | 0.50 | (4.13) | 0.84 | |
Depreciation/Fixed assets |
2.76 | 2.93 | 2.51 | 1.83 | |
Capex/Depreciation |
0.00 | (0.27) | 0.00 | 0.00 | |
Revenue per Share |
0.63 | 0.61 | 0.64 | 0.61 | |
Operating CF per Share |
(0.03) | (0.04) | 0.06 | 0.01 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(16.89%) | (12.41%) | (2.40%) | 1.62% |
Columns are period end dates